Business Wire

Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Technologies announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza virus or RSV. Since initial ...
Healio

Multiplex PCR assay detects four respiratory viruses with single swab

Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...
Labroots

Panel Presentation: Multiplex RT-PCR to Accurately Detect and Differentiate Respiratory Viruses Presenting Similar Clinical Symptoms

Last year, while experts were concerned about the “twindemic”, the flu season was virtually non-existent due to COVID-19 public health countermeasures. With COVID-19 vaccination rollouts and ...
Medscape

Comparison of Three Multiplex PCR Assays for the Detection of Respiratory Viral Infections

The qualitative Respiratory Validation Panel Global (NATRVP-2, ZeptoMetrix Corporation, Buffalo, New York) was quantified by real-time qPCR. External plasmid standards were used to determine the ...
Labroots

Prepare your lab for Flu Season with Multiplex PCR

In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Adenovirus, Human Metapneumovirus, Rhinovirus, Enterovirus, and Parainfluenza, ...
Yahoo Finance

QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus

QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx ...
Yahoo Finance

Molecular Designs Submits Simplicity™DX Respiratory Panel for FDA 510(k) Clearance

BIRMINGHAM, Ala., Oct. 2, 2025 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today announced it has submitted a 510(k) premarket notification ...
Nasdaq

bioMérieux: BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 Obtains FDA Emergency Use Authorization

MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
Nasdaq

Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
FierceBiotech

Biocartis to develop respiratory panel tests with Fast-track diagnostics

Fast-track diagnostics will develop assays for use on Biocartis' Idylla testing platform, which searches for multiple pathogens following a single test, or what's known as syndromic multiplex testing.
BioWorld

Opgen’s multiplex diagnostic panel found to reduce inappropriate antibiotic use

A multicenter study has found that a multiplex diagnostic panel developed by Opgen Inc. can reduce the use of inappropriate antibiotic therapy by 45.1%. Opgen’s Unyvero Hospitalized Pneumonia (HPN) ...